Home/Filings/4/0001179110-20-004142
4//SEC Filing

TIMMINS MEGAN C. 4

Accession 0001179110-20-004142

CIK 0001586105other

Filed

Mar 25, 8:00 PM ET

Accepted

Mar 26, 6:23 PM ET

Size

12.0 KB

Accession

0001179110-20-004142

Insider Transaction Report

Form 4
Period: 2020-03-26
TIMMINS MEGAN C.
General Counsel
Transactions
  • Exercise/Conversion

    Common Stock

    2020-03-26$1.60/sh+14,334$22,93434,334 total
  • Exercise/Conversion

    Restricted Stock Units

    2020-03-26+20,0000 total
    Common Stock (20,000 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2020-03-26+14,3340 total
    Common Stock (14,334 underlying)
  • Exercise/Conversion

    Common Stock

    2020-03-26$1.60/sh+20,000$32,00020,000 total
  • Tax Payment

    Common Stock

    2020-03-26$1.60/sh9,435$15,09624,899 total
Footnotes (4)
  • [F1]Represents shares withheld to pay taxes applicable to vesting of restricted stock units.
  • [F2]Restricted Stock Units convert into Common Stock on a one-for-one basis.
  • [F3]On March 26, 2019 the reporting person was granted 43,000 time-based restricted stock units that were eligible to vest 1/3 on each of the first three anniversaries of the grant date.
  • [F4]On March 26, 2019 the reporting person was granted 20,000 time-based restricted stock units that were eligible to vest on the first anniversary of the grant date.

Issuer

Zyla Life Sciences

CIK 0001586105

Entity typeother

Related Parties

1
  • filerCIK 0001733798

Filing Metadata

Form type
4
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 6:23 PM ET
Size
12.0 KB